A detailed history of Lpl Financial LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 10,001 shares of CAPR stock, worth $180,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,001
Previous 31,988 68.74%
Holding current value
$180,918
Previous $152,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$3.56 - $15.21 $78,273 - $334,422
-21,987 Reduced 68.74%
10,001 $152,000
Q2 2024

Aug 07, 2024

SELL
$4.63 - $7.09 $66,440 - $101,741
-14,350 Reduced 30.97%
31,988 $152,000
Q1 2024

May 10, 2024

SELL
$3.61 - $6.88 $115,159 - $219,472
-31,900 Reduced 40.77%
46,338 $314,000
Q4 2023

Feb 14, 2024

SELL
$2.71 - $5.08 $8,130 - $15,240
-3,000 Reduced 3.69%
78,238 $382,000
Q3 2023

Nov 13, 2023

BUY
$3.42 - $7.85 $9,582 - $21,995
2,802 Added 3.57%
81,238 $277,000
Q2 2023

Jul 31, 2023

BUY
$3.76 - $5.05 $294,919 - $396,101
78,436 New
78,436 $374,000

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $440M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.